Morning Overview on MSN
The FDA cleared Xocova, the first oral antiviral to prevent COVID-19 after exposure, in a five-day pill course shown to cut infections in a phase 3 trial
Households where someone tests positive for COVID-19 now have an oral drug option to protect the people around them. The FDA ...
Yearly Covid-19 Booster Recommendations in Canada, Europe, and Australia. Although the rapid development of multiple Covid-19 vaccines in 2020 represents a major scientific, medical, and regulatory ...
When the University of Alabama at Birmingham School of Nursing transitioned to remote teaching in late March to promote safety and social distancing in the face of the novel coronavirus (COVID-19), ...
For many parents, the decision to vaccinate their children was made so long ago they haven’t given much thought to the ongoing debate over safety and efficacy. Those are the parents likely to be most ...
The U.S. is experiencing another uptick in COVID infections after the holidays, with hospitalizations rising for the eighth week in a row. A new dominant variant, JN.1, has quickly spread to account ...
CLEVELAND, Ohio — So far during this year’s winter virus season, more Americans have gotten the flu and COVID-19 vaccines than at the same time last year, the U.S. Centers for Disease Control and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results